Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuron (IMRN) Liabilities and Shareholders Equity (2016 - 2025)

Immuron has reported Liabilities and Shareholders Equity over the past 10 years, most recently at $6.5 million for Q2 2025.

  • For Q2 2025, Liabilities and Shareholders Equity fell 36.69% year-over-year to $6.5 million; the TTM value through Jun 2025 reached $24.8 million, down 0.64%, while the annual FY2025 figure was $6.6 million, 35.62% down from the prior year.
  • Liabilities and Shareholders Equity for Q2 2025 was $6.5 million at Immuron, down from $8.0 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $17.3 million in Q3 2022 and troughed at $129434.6 in Q4 2023.
  • A 5-year average of $6.8 million and a median of $6.5 million in 2025 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 6335.21% in 2022 and later crashed 99.21% in 2023.
  • Year by year, Liabilities and Shareholders Equity stood at $253772.8 in 2021, then surged by 6335.21% to $16.3 million in 2022, then tumbled by 99.21% to $129434.6 in 2023, then skyrocketed by 6048.66% to $8.0 million in 2024, then decreased by 18.48% to $6.5 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for IMRN at $6.5 million in Q2 2025, $8.0 million in Q4 2024, and $155499.7 in Q3 2024.